A nationwide recall of griseofulvin oral suspension 125 mg/5 ml
A nationwide recall of griseofulvin oral suspension 125 mg/5 ml (Grifulvin, Ortho-McNeil) has been instated following two reports of glass fragments found in bottles of the liquid formulation. In addition, griseofulvin oral suspension, manufactured by Ortho-McNeil but with a Patriot Pharmaceuticals L.L.C. label, is also affected. The bottles were shipped to distributors between Aug. 23, 2005, and March 14, 2007, and the affected lot numbers are listed on-line at
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.